IRVINE, CA - SenoRx Inc. announced in a press release that a jury delivered a verdict in favor of SenoRx in a lawsuit brought by Hologic Inc., Cytyc Corp., and Hologic L.P. in the US District Court for the Northern District of California.
Hologic had alleged that SenoRx infringed claims of Hologic's 6,413,204 and 6,482,142 patents. SenoRx claimed that both patents were invalid, and that the '204 patent was not infringed.
The jury found that SenoRx was not liable for infringement of the '204 patent and that both patents were invalid. Lloyd Malchow, SenoRx Chairman and Chief Executive Officer, said, "We are pleased with the jury's verdict. We have been steadfast from the beginning and confident in our position. We look forward to focusing all of management's time on continuing to develop innovative new products to assist and improve the medical community's ability to diagnose and more effectively treat breast cancer."
SenoRx develops, manufactures and sells minimally invasive medical devices used by breast care specialists for the diagnosis and treatment of breast cancer, including its EnCor vacuum-assisted breast biopsy system and Contura MLB catheter for delivering radiation to the tissue surrounding the lumpectomy cavity following surgery for breast cancer.
